Inari Medical stock skyrocketed Tuesday after Stryker agreed to buy the medical devices company for $4.9 billion. Please watch the video at Investors.com - How To Buy Stocks: Ways To Profit From ...
Inari Medical announced the launch of its Artix thrombectomy system for arterial thromboembolism. According to the company, ...
GlobalData on MSN13d
Inari Medical introduces thrombectomy system for arterial thrombus casesInari Medical has launched the Artix thrombectomy system, a medical device engineered specifically for certain requirements ...
Inari Medical, Inc. (NASDAQ:NARI) is a medical device company that develops, manufactures, and markets devices for the interventional treatment of venous diseases. Its products primarily comprise ...
Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its Artix ...
Stryker Corp. yesterday announced that it completed its acquisition of Irvine-based medical device maker Inari Medical Inc. for $4.9 billion. The acquisition closed less than two months after the deal ...
Inari Medical, Inc. (NASDAQ:NARI) is a medical device company that develops, manufactures, and markets devices for the interventional treatment of venous diseases. Its products primarily comprise ...
Charles Schwab Investment Management Inc. grew its position in shares of Inari Medical, Inc. (NASDAQ:NARI – Free Report) by 2 ...
Inari Medical — now part of Stryker — announced that it launched its Artix thrombectomy system for arterial thrombectomies.
However, existing therapies for arterial thromboembolism can lead to: The Artix System builds on the success of Inari's venous thrombectomy devices and is its inaugural entry into the arterial space.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results